MD Stock Cash Flow Statements

MEDNAX Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

MEDNAX Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31

cash flows from operating activities:
net income	39,260,000	20,737,000	30,480,000	19,441,000	-153,025,000	4,035,000	-124,287,000	21,391,000	28,282,000	14,206,000	29,659,000	30,728,000	27,136,000	-21,188,000	47,516,000	30,795,000	35,011,000	17,642,000	-64,296,000	-41,044,000	-672,436,000	-18,712,000	9,331,000	-1,255,916,000	-8,245,000	-242,872,000	60,214,000	65,575,000	79,412,000	63,428,000	136,103,000	65,880,000	63,698,000	54,691,000	78,079,000	96,421,000	82,325,000	67,771,000	92,414,000	90,640,000	84,048,000	68,589,000	88,280,000	86,238,000	79,025,000	63,660,000	78,974,000	76,958,000	69,218,000	55,367,000	66,103,000	65,910,000	60,544,000	48,350,000	58,359,000	58,241,000	55,941,000	45,456,000	53,800,000	61,270,000	49,358,000	38,263,000	50,401,000	48,134,000	43,217,000	34,052,000	38,985,000	37,396,000	37,014,000	55,806,000	41,267,000	39,558,000	36,315,000	25,582,000			15,870,000	28,057,000	27,127,000	17,983,000	25,785,000	25,943,000	25,235,000	21,316,000	23,971,000	23,473,000	19,885,000	16,999,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	5,313,000	5,332,000	6,873,000	6,254,000	8,791,000	10,308,000	9,062,000	9,211,000	8,945,000	8,953,000	9,136,000	8,956,000	8,775,000	8,769,000	7,859,000	8,151,000	8,106,000	8,031,000	7,692,000	-8,043,000	10,119,000	18,673,000	19,410,000	19,608,000	19,809,000	20,033,000	29,891,000	28,709,000	26,518,000	26,163,000	26,414,000	25,116,000	25,735,000	25,614,000	25,254,000	24,185,000	20,241,000	19,584,000	18,149,000	16,918,000	15,549,000	13,612,000	13,902,000	11,356,000	10,362,000	10,370,000	10,491,000	10,461,000	9,870,000	9,144,000	8,091,000	7,925,000	7,687,000	7,113,000	7,266,000	6,213,000	6,032,000	5,781,000	5,843,000	6,321,000	5,006,000	4,780,000	4,610,000	3,956,000	4,187,000	3,963,000	4,020,000	3,296,000	2,939,000	2,955,000	3,047,000	2,577,000	2,466,000	2,473,000			2,400,000	2,339,000	2,529,000	2,647,000		2,299,000	2,337,000	2,363,000
amortization of premiums, discounts and issuance costs	228,000	230,000	251,000	263,000	240,000	200,000	224,000	282,000	340,000	393,000	419,000	489,000	280,000	577,000	815,000	1,682,000	844,000	994,000	3,087,000	1,291,000	1,327,000	1,458,000	1,379,000	1,359,000	1,414,000	1,520,000	1,258,000	1,102,000	1,123,000	1,089,000	1,436,000	1,338,000	1,357,000	1,383,000	739,000	1,384,000	1,397,000	1,296,000
impairment losses
loss on disposal of businesses				59,000
stock-based compensation expense	3,909,000	3,641,000	2,739,000	4,110,000	1,952,000	3,067,000	3,024,000	3,164,000	3,126,000	3,009,000	3,236,000	4,120,000	4,336,000	4,435,000	4,021,000	5,495,000	5,735,000	3,717,000	2,922,000	22,301,000	5,784,000	8,035,000	6,379,000	8,022,000	9,961,000	10,989,000	9,359,000	8,945,000	10,524,000	9,875,000	7,040,000	7,752,000	7,245,000	7,536,000	8,111,000	8,649,000	8,327,000	8,913,000	8,169,000	8,196,000	7,928,000	7,836,000	7,805,000	8,065,000	7,778,000	8,071,000	8,099,000	8,097,000	7,808,000	7,284,000	7,996,000	7,352,000	6,053,000	7,036,000	7,055,000	6,832,000	6,693,000	6,512,000	6,594,000	6,665,000	6,315,000	6,119,000	6,434,000	6,472,000	5,731,000	5,683,000	5,514,000	5,373,000	4,942,000	4,947,000	5,278,000	4,361,000	3,846,000	4,476,000
deferred income taxes	12,106,000	4,398,000	13,750,000	9,148,000	-25,714,000	686,000	-7,350,000	2,213,000	6,368,000	2,008,000	-14,069,000	-6,808,000	-4,283,000	2,389,000	-1,048,000	-13,158,000	-1,017,000	-16,016,000	6,078,000	-25,598,000	22,230,000	33,582,000	-22,311,000	-143,736,000	-5,845,000	-5,108,000	-7,221,000	4,283,000	-21,256,000	45,000	-76,804,000	-1,723,000	16,270,000	2,184,000	1,873,000	-1,805,000	15,486,000	2,595,000	11,624,000	-14,665,000	15,512,000	2,023,000	-7,851,000	2,918,000	7,879,000	-387,000	-3,420,000	3,130,000	20,582,000	-4,372,000	4,613,000	6,407,000	21,460,000	-11,136,000	2,509,000	1,367,000	2,924,000	1,263,000	18,143,000	816,000	7,231,000	-1,815,000	9,211,000	1,229,000	3,927,000	-6,920,000	-20,415,000	-3,213,000	4,986,000	4,993,000	-5,477,000	-7,417,000	5,648,000	230,000			833,000	-4,093,000	4,202,000	609,000		616,000	363,000	6,188,000
other	-743,000	-758,000	-966,000	-328,000	-413,000	-1,265,000	-1,560,000	-707,000	-509,000	-391,000	2,523,000	-802,000	-972,000	-605,000	-711,000	-434,000	-567,000	-638,000	-168,000	2,062,000	-209,000	-1,883,000	1,458,000	-14,219,000	10,383,000	2,767,000	-7,873,000	-882,000	-932,000	-1,216,000	-1,303,000	927,000	-651,000	-2,756,000
changes in assets and liabilities:
accounts receivable	3,770,000	17,461,000	9,657,000	1,569,000	9,002,000	-9,936,000	4,181,000	-6,805,000	7,555,000	21,345,000	-5,042,000	15,449,000	4,202,000	-20,152,000	-30,704,000	-16,022,000	-14,372,000	-11,633,000	7,931,000	-14,290,000	18,392,000	25,904,000	-4,170,000	9,491,000	18,448,000	-15,915,000	-17,771,000	5,171,000	14,612,000	-38,610,000	16,888,000	-27,446,000	7,283,000	11,078,000	-9,188,000	-8,584,000	4,861,000	-21,089,000	-37,768,000	-15,498,000	6,558,000	-8,683,000	-7,022,000	-7,983,000	-11,721,000	-30,292,000	-12,583,000	-3,040,000	-5,954,000	-15,754,000	2,441,000	-9,587,000	-4,203,000	-6,329,000	-23,328,000	-13,028,000	-5,862,000	-6,775,000	-6,673,000	4,261,000	-4,998,000	-9,541,000	-421,000	-588,000	1,793,000	-2,833,000	-10,985,000	-2,805,000	-4,571,000	1,432,000	-4,551,000	-9,979,000	-5,063,000	-2,200,000			-1,851,000	-4,024,000	-441,000	2,451,000		-8,055,000	-2,406,000	-3,726,000
prepaid expenses and other current assets	1,329,000	-1,125,000	-2,448,000	2,242,000	-53,000	3,756,000	-3,776,000	2,149,000	6,611,000	-4,470,000	-6,781,000	5,665,000	832,000	16,212,000	15,139,000	-14,409,000	-6,999,000	47,799,000	-46,240,000	14,565,000	-21,382,000	5,101,000	-2,378,000	-8,425,000	-3,985,000	4,790,000	-121,000	-4,173,000	-2,139,000	961,000	-3,039,000	913,000	-3,808,000	3,142,000	338,000																																													1,584,000				571,000
other long-term assets	4,952,000	4,649,000	3,159,000	13,614,000	11,055,000	5,900,000	9,508,000	8,291,000	4,100,000	952,000	6,036,000	4,190,000	6,107,000	863,000	387,000	11,271,000	-1,769,000	-90,000	6,213,000	2,143,000	-5,629,000	11,189,000	7,461,000	16,492,000	4,456,000	9,580,000	1,559,000			-517,000					-244,000	9,484,000
accounts payable and accrued expenses	69,734,000	-159,685,000	85,294,000	48,763,000	58,546,000	-141,463,000	44,197,000	41,197,000	52,810,000	-150,125,000	76,859,000	14,547,000	68,285,000	-159,271,000	26,642,000	49,137,000	52,484,000	-106,937,000	84,341,000	50,176,000	111,843,000	-198,452,000	79,682,000	81,584,000	75,454,000	-132,559,000	53,525,000	62,307,000	35,866,000	-136,308,000	34,349,000	78,064,000	64,005,000	-151,867,000	44,245,000	59,208,000	43,520,000	-135,356,000	44,860,000	66,793,000	50,095,000	-169,622,000	78,612,000	51,776,000	67,021,000	-131,370,000	52,582,000	50,066,000	54,315,000	-107,724,000	31,652,000	43,034,000	56,629,000	-114,362,000	34,662,000	38,988,000	37,548,000	-89,718,000	8,407,000	25,059,000	37,847,000	-108,316,000	26,354,000	43,908,000	47,081,000	-77,862,000	67,174,000	32,629,000	32,483,000	-73,346,000	39,733,000	32,783,000	33,438,000	-60,764,000			29,536,000	19,887,000	21,347,000	-35,012,000		20,777,000	15,992,000	-37,554,000
income taxes payable	2,015,000	2,748,000		-4,208,000	8,718,000	3,017,000		6,874,000	-17,327,000	5,299,000												-32,883,000	1,718,000	3,105,000	-43,315,000	14,373,000	8,930,000	-30,277,000	-1,124,000	-38,785,000	47,628,000	41,322,000	-44,879,000	28,979,000	-11,164,000	15,066,000	-25,565,000	19,429,000	-20,055,000	28,089,000	-31,687,000	19,552,000	1,496,000	2,493,000	-23,067,000	26,076,000	906,000	8,790,000	-31,553,000	27,629,000	-7,185,000	3,154,000	-33,635,000	30,323,000	4,966,000	-683,000	-12,755,000	15,176,000	1,148,000	3,495,000	-10,018,000	24,081,000	-20,336,000	-274,000	-17,953,000	19,679,000	-8,354,000	3,534,000	-22,498,000	22,616,000	14,267,000	2,052,000	-771,000	-9,454,000			-4,497,000	13,788,000	53,000	10,463,000				2,887,000
long-term professional liabilities	-576,000	-7,590,000	4,064,000	5,200,000	3,957,000	4,082,000	-1,000	0	-1,540,000	2,378,000	-1,760,000	10,128,000	-5,452,000	2,684,000	966,000	1,272,000	201,000	-916,000	-11,367,000	12,772,000	-4,038,000	6,969,000	9,023,000	4,295,000	-2,978,000	-496,000	-1,882,000	3,255,000	-5,220,000	-643,000	9,677,000	7,785,000	2,521,000	-1,505,000	-6,905,000	-69,000	1,921,000	1,601,000	-4,878,000	-2,475,000	344,000	4,945,000	-291,000	5,151,000	-1,995,000	6,419,000	2,448,000	5,387,000	4,814,000	7,148,000	-4,122,000	7,343,000	3,786,000	2,934,000	-2,064,000	5,144,000	2,647,000	4,116,000
other liabilities	-3,166,000	-6,149,000	-652,000	-10,402,000	-6,619,000	-5,011,000	-12,008,000	-6,144,000	-6,155,000	-4,201,000	-9,690,000	-9,442,000	-1,744,000	877,000	-2,701,000	-9,404,000	14,207,000	-24,620,000	-4,639,000	-18,731,000	34,800,000	-7,912,000	-2,607,000	-10,275,000	-3,612,000	-11,993,000	-1,867,000	-1,030,000	-2,346,000	949,000	-1,519,000	-1,498,000	123,000	2,159,000	738,000	-10,610,000	2,138,000	329,000	-1,471,000	-6,411,000	1,364,000	3,864,000	-219,000	239,000	1,269,000	1,203,000	-500,000	-681,000	1,019,000	1,373,000	-2,230,000	175,000	910,000	1,556,000	-1,097,000	499,000	1,343,000	1,214,000	-169,000	-2,857,000	1,267,000	1,608,000	-1,268,000	189,000	1,560,000	915,000	-4,121,000	5,886,000	2,215,000	-9,205,000	1,297,000	-954,000	-6,378,000	7,936,000
net cash from operating activities – continuing operations	138,131,000	-116,111,000	134,805,000	95,725,000	109,344,000	-122,624,000	73,003,000	81,116,000	92,606,000	-100,644,000	102,293,000	88,353,000	81,597,000	-89,931,000	75,042,000	67,202,000	70,442,000	-98,926,000	82,243,000	51,752,000	166,324,000	-146,431,000			115,330,000	-60,408,000
net cash from operating activities - discontinued operations	-964,000	-1,352,000		-3,887,000	-2,393,000	-2,602,000		-1,178,000	-3,552,000	-273,000		-5,023,000	810,000	-7,551,000		-6,100,000	-16,855,000	16,738,000						257,000	4,322,000	3,591,000
net cash from operating activities	137,167,000	-117,463,000	133,010,000	91,838,000	106,951,000	-125,226,000	69,250,000	79,938,000	89,054,000	-100,917,000	98,686,000	83,330,000	82,407,000	-97,482,000	44,236,000	61,102,000	53,587,000	-82,188,000	-11,866,000	169,935,000	192,982,000	-146,431,000	127,621,000	156,181,000	119,652,000	-56,817,000				-113,634,000				-21,763,000				-33,039,000				-53,684,000				-49,822,000				-18,387,000				-32,116,000				-14,461,000				-41,606,000				-22,025,000				-27,313,000				-30,776,000										-7,874,000
capex	-4,515,000	-3,318,000	-3,440,000	-6,290,000	-6,962,000	-5,330,000	-9,044,000	-9,154,000	-8,131,000	-6,999,000	-9,058,000	-6,947,000	-6,558,000	-7,145,000	-3,168,000	-10,545,000	-9,484,000	-9,052,000	-6,979,000	1,517,000	-9,613,000	-13,713,000	-6,872,000	-8,529,000	-10,659,000	-5,821,000				-12,426,000				-11,730,000				-10,443,000				-5,388,000				-4,570,000				-4,337,000				-2,920,000				-20,250,000				-4,062,000				-4,484,000				-4,912,000				-1,469,000										-2,399,000
free cash flows	132,652,000	-120,781,000	129,570,000	85,548,000	99,989,000	-130,556,000	60,206,000	70,784,000	80,923,000	-107,916,000	89,628,000	76,383,000	75,849,000	-104,627,000	41,068,000	50,557,000	44,103,000	-91,240,000	-18,845,000	171,452,000	183,369,000	-160,144,000	120,749,000	147,652,000	108,993,000	-62,638,000				-126,060,000				-33,493,000				-43,482,000				-59,072,000				-54,392,000				-22,724,000				-35,036,000				-34,711,000				-45,668,000				-26,509,000				-32,225,000				-32,245,000										-10,273,000
cash flows from investing activities:
acquisition payments, net of cash acquired			0	0	0	-8,167,000	-5,000,000	0	0	-1,667,000	0	0	-2,500,000	-25,667,000	-10,380,000	-12,343,000	-1,250,000	-5,957,000	0	-2,150,000	0	-75,000	-80,775,000	-19,750,000	-7,200,000	-4,250,000	-87,456,000	-1,460,000	-3,600,000	-21,975,000	-176,612,000	-241,338,000	-2,801,000	-110,945,000	-37,441,000	-529,146,000	-136,175,000	-59,540,000	-12,599,000	-236,839,000	-531,741,000	-37,724,000	-133,323,000	-210,574,000	-66,122,000	-69,375,000	-44,500,000	-76,601,000	-115,649,000	-1,295,000	-238,644,000	-137,493,000	-36,774,000	-28,095,000	-74,957,000	-68,395,000	-1,450,000	-10,083,000	-274,460,000	-5,601,000	-18,350,000	-40,185,000	-47,950,000	-41,148,000	-50,720,000	-11,503,000			-41,099,000	-6,555,000	-17,008,000	-89,441,000	-694,000	-11,958,000			-6,217,000	-19,869,000	-28,931,000	-36,920,000	-23,166,000	-2,977,000	-30,029,000	-8,681,000	-11,934,000	-17,112,000
purchases of investments	-13,768,000	-7,761,000	-10,144,000	-14,487,000	-23,019,000	-16,896,000	-5,416,000	-8,716,000	-8,212,000	-9,549,000	-2,408,000	-1,955,000	-11,711,000	-1,272,000	-3,621,000	-3,076,000	-3,217,000	-5,138,000	-25,755,000	-3,755,000	-11,293,000	-21,042,000	-21,194,000				0	0	-1,845,000	-14,039,000	-2,982,000	-9,417,000	-2,919,000	-12,405,000	-10,108,000	-12,189,000	-20,388,000	-18,291,000	-13,598,000	-9,434,000	-7,229,000	-3,719,000	-7,280,000	-9,878,000	-5,822,000	-3,904,000	-1,936,000	-3,920,000	-2,928,000	-12,018,000	-12,021,000	-6,986,000	-8,537,000	-5,576,000	-16,487,000	-18,117,000	-322,000	-7,600,000	-5,056,000	-16,227,000	-2,848,000	-2,347,000												-13,538,000
proceeds from maturities or sales of investments	11,080,000	7,300,000	7,170,000	14,080,000	17,089,000	14,155,000	6,345,000	3,750,000	5,945,000	6,865,000	1,000,000	1,850,000	6,327,000	7,712,000	1,001,000	4,750,000	3,312,000	7,433,000	2,567,000	12,730,000	8,275,000	9,860,000	24,865,000	18,060,000	3,380,000	4,800,000
purchases of property and equipment	-4,515,000	-3,318,000	-3,440,000	-6,290,000	-6,962,000	-5,330,000	-9,044,000	-9,154,000	-8,131,000	-6,999,000	-9,058,000	-6,947,000	-6,558,000	-7,145,000	-3,168,000	-10,545,000	-9,484,000	-9,052,000	-6,979,000	1,517,000	-9,613,000	-13,713,000	-6,872,000	-8,529,000	-10,659,000	-5,821,000	-10,733,000	-11,861,000	-13,848,000	-12,426,000	-17,333,000	-10,067,000	-10,179,000	-11,730,000	-10,844,000	-9,249,000	-8,728,000	-10,443,000	-7,165,000	-7,239,000	-7,281,000	-5,388,000	-6,656,000	-3,652,000	-3,183,000	-4,570,000	-2,970,000	-3,339,000	-5,008,000	-4,337,000	-4,548,000	-3,126,000	-3,901,000	-2,920,000	-2,710,000	-5,203,000	-3,169,000	-20,250,000	-2,059,000	-2,834,000	-3,158,000	-4,062,000												-1,469,000
net cash from investing activities	-7,154,000	-7,464,000	-1,938,000	-4,338,000	-12,892,000	-16,238,000	-12,424,000	-14,004,000	-10,398,000	-11,350,000	-11,241,000	-6,088,000	-13,352,000	-26,273,000	-15,584,000	-41,214,000	14,089,000	-10,364,000	840,611,000	-3,441,000	-1,439,000	-20,220,000	156,977,000	-27,219,000	-18,612,000	-8,691,000	-94,989,000	-8,806,000	-16,798,000	-22,176,000	-189,136,000	-247,656,000	-12,361,000	-127,460,000	-49,308,000	-543,364,000	-152,401,000	-76,144,000	-24,614,000	-244,332,000	-535,488,000	-43,566,000	-141,024,000	-217,654,000	-70,712,000	-74,214,000	-44,708,000	-79,810,000	-123,337,000	-15,635,000	-251,103,000	-134,442,000	-45,612,000	-29,391,000	-84,569,000	-79,185,000	6,264,000	-33,083,000	-277,600,000	-17,162,000	-23,356,000	-43,494,000	-47,366,000				-35,764,000				-7,066,000						-8,595,000	-24,799,000	-31,636,000	-39,822,000		-4,398,000	-30,336,000	-11,080,000
cash flows from financing activities:
borrowings on line of credit				0	65,000,000	170,500,000																																						450,000,000	262,500,000	371,500,000	79,500,000	267,000,000	269,500,000	295,500,000	116,000,000	155,500,000	113,000,000	133,000,000	125,000,000	147,500,000	92,500,000	147,500,000	324,500,000	21,500,000	108,500,000	229,500,000	141,000,000	70,500,000	76,000,000	186,000,000	110,000,000	263,100,000	60,700,000	16,000,000										28,000,000						-2,500,000
payments on line of credit				0	-145,000,000	-90,500,000																																						-341,000,000	-332,000,000	-150,500,000	-176,000,000	-297,300,000	-299,700,000	-255,500,000	-20,000,000	-107,500,000	-196,500,000	-78,500,000	-146,000,000	-163,500,000	-203,000,000	-117,500,000	-178,000,000	-79,500,000	-179,500,000	-150,500,000	-176,500,000	-137,000,000	-105,000,000	-144,500,000	-141,500,000	-149,600,000	-3,200,000	-16,000,000								-45,200,000
payments on term loan	-4,687,000	-4,688,000	-3,125,000	-3,125,000	-3,125,000	-3,125,000	-3,125,000	-3,125,000	-3,125,000	-3,125,000	-3,125,000	-3,125,000
payments on finance lease obligations	-505,000	-339,000	-843,000	-654,000	-701,000	-690,000	-513,000	-701,000	-701,000	-703,000	-740,000	-914,000	-515,000	-747,000	-1,013,000	-690,000	-434,000	-672,000	-728,000	-247,000	-183,000	-3,000	-51,000	-85,000	-56,000	-42,000
proceeds from issuance of common stock	1,176,000	662,000	732,000	897,000	1,149,000	860,000	1,036,000	1,187,000	1,594,000	1,095,000	1,176,000	1,382,000	1,664,000	1,174,000	1,242,000	3,033,000	1,536,000	1,042,000	1,312,000	1,321,000	2,544,000	1,832,000	2,101,000	2,606,000	3,675,000	2,876,000	3,006,000	3,863,000	5,658,000	3,731,000	4,592,000	4,694,000	6,913,000	7,077,000	6,423,000	4,144,000	7,058,000	4,397,000	3,406,000	5,766,000	6,360,000	4,596,000	18,736,000	5,752,000	10,990,000	7,398,000	13,340,000	5,182,000	4,982,000	5,193,000	9,983,000	5,024,000	4,541,000	9,262,000	3,054,000	5,207,000	16,966,000	6,135,000	12,961,000	1,560,000	4,818,000	3,193,000	10,760,000	3,966,000	2,291,000	942,000	1,417,000	1,680,000	3,003,000	5,582,000	2,481,000	19,657,000	2,053,000	3,197,000			17,258,000	8,874,000	16,819,000	8,472,000	6,430,000	3,946,000	7,855,000	15,463,000	7,509,000	9,210,000	10,282,000	935,000
repurchases of common stock	-209,000	-1,569,000	-643,000	-162,000	-11,000	-887,000	0	-133,000	-11,000	-775,000	-1,470,000	-21,477,000	-64,398,000	-1,166,000	0	-2,474,000	-251,000	-1,994,000	2,000	-5,452,000	-501,000	-2,542,000	-355,000	-416,000	-65,527,000	-78,982,000	0	-250,000,000			0	0	-2,078,000	-68,114,000	0	0	-3,182,000	-58,646,000	0	-1,450,000	0	-233,601,000	-360,670,000	-1,063,000	-9,707,000	-116,989,000	0																				0	0	-99,997,000	-100,000,000	-32,607,000
net cash from financing activities	-4,259,000	-6,035,000	-4,963,000	-3,071,000	-82,655,000	76,204,000	-4,747,000	-50,604,000	-78,931,000	108,567,000	-86,289,000	-82,662,000	-62,146,000	-256,457,000	825,000	-131,000			586,000	-4,133,000			-209,499,000	-143,150,000																																							-19,914,000														-32,816,000					-31,474,000
net decrease in cash and cash equivalents	125,754,000	-130,962,000			11,404,000	-65,260,000			-275,000	-3,700,000		-5,420,000	6,909,000	-380,212,000										-14,188,000				-3,595,000	-2,883,000	-19,261,000																											8,915,000	-11,202,000																					1,534,000	-2,931,000			-4,595,000	-3,582,000
cash and cash equivalents at beginning of period	0	229,940,000		0	0	73,258,000		0	0	9,824,000		0	0	387,391,000		0	0	1,123,843,000		0	-4,897,000	112,767,000										0	0	55,698,000		0	0	51,572,000		0	0	47,928,000		0	0	31,137,000		0	0	21,280,000		0	0	18,596,000		0	0	26,251,000		0	0	26,503,000		0	0	14,346,000		0	0	102,843,000		0	0	69,595,000				0	0	7,011,000		0	0	27,896,000		0	0	73,195,000
cash and cash equivalents at end of period	125,754,000	98,978,000		84,429,000	11,404,000	7,998,000		15,330,000	-275,000	6,124,000		-5,420,000	6,909,000	7,179,000		19,757,000	68,527,000	269,630,000		162,361,000												7,980,000	-1,416,000	41,839,000		913,000	-3,599,000	55,491,000		-4,407,000	15,103,000	50,219,000		54,109,000	-2,062,000	19,775,000		3,079,000	-21,262,000	34,425,000		53,978,000	-10,242,000	22,388,000		11,785,000	8,915,000	15,049,000		35,246,000	2,202,000	23,939,000		2,265,000	-2,743,000	21,343,000		-2,097,000	-25,255,000	39,488,000		-86,099,000	64,974,000	71,632,000				-836,000	1,534,000	4,080,000		11,188,000	-4,595,000	24,314,000		-1,144,000	-2,074,000	13,628,000
income from discontinued operations																				33,126,000	682,397,000	2,602,000
adjustments to reconcile net income to net cash provided from operating activities:
loss on disposal of business
loss on early extinguishment of debt											0	0	0	57,016,000	0	0	0	14,532,000
income taxes (payable) receivable
net used in operating activities – discontinued operations
borrowings on credit agreement							0	49,000,000	205,000,000	216,000,000			226,500,000	248,500,000					0	0	12,500,000	515,000,000	21,500,000	327,300,000	380,000,000	518,500,000	359,000,000	543,000,000	315,500,000	506,000,000	1,590,000,000	435,000,000	284,500,000	536,500,000	279,000,000	759,000,000	352,000,000	550,000,000
payments on credit agreement							0	-90,000,000	-278,000,000	-106,000,000			-222,000,000	-99,500,000					0	0	-381,000,000	-146,500,000	-231,300,000	-469,000,000	-420,500,000	-866,000,000	-883,500,000	-428,500,000	-390,000,000	-392,500,000	-1,563,500,000	-381,500,000	-414,000,000	-340,000,000	-362,000,000	-410,500,000	-355,500,000	-382,000,000
redemption of senior notes, including call premium											0	0	0	-1,046,880,000	0	0	0	-759,848,000
proceeds from issuance of senior notes and term loan
payments for credit facility amendment and financing costs																			0	0	-10,000	-500,000
payments of contingent consideration liabilities															0	0	0	-189,000			0	-102,000	-406,000	-346,000	-376,000	-42,000	-407,000	-621,000	0	-65,000	-176,000	-275,000	-255,000	-44,000	-302,000	-234,000	-472,000	-29,000	-394,000	-253,000	-758,000	-34,000	-220,000	-84,000	-988,000	-2,779,000									-2,861,000	0
net increase in cash and cash equivalents			126,109,000				52,079,000								29,477,000	19,757,000	68,527,000	-854,213,000	829,331,000	162,361,000	-175,107,000	199,388,000				1,156,000					31,797,000	7,980,000	-1,416,000	-13,859,000	2,893,000	913,000	-3,599,000	3,919,000	-9,343,000	-4,407,000	15,103,000	2,291,000	-23,894,000			-11,362,000	14,895,000			13,145,000	-44,844,000			3,792,000	-17,153,000				-35,136,000	35,246,000	2,202,000	-2,564,000	5,638,000	2,265,000	-2,743,000	6,997,000			-25,255,000	-63,333,000	52,386,000	-86,099,000	64,974,000	2,037,000			6,414,000				-23,896,000				17,486,000	-1,144,000	-2,074,000	-59,567,000
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
supplemental disclosure of cash flow information:
cash paid for:
interest
income taxes											26,109,000
non-cash investing and financing activities:
equipment financed through finance leases
property and equipment included in accounts payable
goodwill impairment				0																			0
fixed assets impairments				0
intangible assets impairments				0
gain on sale of building															0	0
proceeds from sale of building															0	0
strategic investments															0
net cash from investing activities – continuing operations											-11,241,000	-6,088,000	-13,352,000	-26,273,000	-15,584,000	-41,214,000	14,089,000	-12,714,000	-30,167,000	8,946,000	-16,905,000	-20,220,000			-14,479,000	-5,271,000
net cash from investing activities – discontinued operations
net cash from financing activities – continuing operations											-86,289,000	-82,662,000	-62,146,000	-256,457,000					586,000	-2,885,000
net cash from financing activities – discontinued operations
proceeds from senior notes and term loan												0	0	650,000,000
payments for financing costs												-227,000	-470,000	-7,924,000									0	0	-814,000	-8,380,000
(income) income from discontinued operations															-7,234,000	1,052,000	-4,478,000	-12,290,000
income taxes receivable													-29,470,000	17,216,000	14,106,000	11,774,000	-9,664,000	-18,501,000
payment of contingent consideration liabilities																																																-600,000	-5,300,000	-410,000		0	-4,493,000	-410,000
net cash from operating activities – discontinued operations
contribution from noncontrolling interests																			0												0	0	0	894,000									0	0
cash, cash equivalents at beginning of year
cash paid (refunded) for:
loss (income) from discontinued operations														247,000									23,652,000	-4,330,000	43,761,000	284,525,000
net cash from investing activities - discontinued operations																0	0	2,350,000						-3,093,000	-4,133,000	-3,420,000
borrowings on revolving credit line
payments on revolving credit line
net cash from financing activities - discontinued operations
proceeds from issuance of senior notes																							0	0	0	500,000,000
payments for credit facility amendment																																								0
contribution from noncontrolling interest
net cash from from financing activities – continuing operations
net cash (used in) provided from financing activities – continuing operations
net cash provided from financing activities – continuing operations																		-761,661,000				366,039,000				66,664,000
net cash provided from financing activities - discontinued operations
net cash provided from financing activities																		-761,661,000				366,039,000				66,664,000				116,549,000	25,298,000	55,706,000	-126,631,000	135,364,000	-78,747,000	348,151,000	-941,000	113,102,000		67,809,000	404,458,000	99,541,000			-65,593,000	112,674,000				47,167,000				65,299,000				36,342,000			-66,135,000	82,536,000											3,280,000	3,524,000						36,235,000
proceeds from sales of businesses, net of cash sold
income taxes payable / receivable																				20,920,000
net cash from operating activities—discontinued operations
proceeds from sale of business, net of cash sold																				604,000
net cash from investing activities—discontinued operations																				-12,387,000
net cash from financing activities—discontinued operations
proceeds from sale of business																						4,750,000
less cash and cash equivalents of discontinued operations at end of period																								2,836,000	-189,000	-11,425,000
cash and cash equivalents of continuing operations at end of period																						312,155,000
proceeds from sales of businesses
cash, cash equivalents and restricted cash at beginning of year
less cash and cash equivalents of discontinued operations at end of year
cash and cash equivalents and restricted cash at end of year
value of common stock issued for acquisitions
net cash from operating activities - continuing operations
proceeds from sale of controlling interest in assets																											0	0	0	22,764,000
net cash from investing activities - continuing operations
net cash from financing activities - continuing operations
cash, cash equivalents and restricted cash at beginning of period																								0	0	56,745,000		0	0	80,200,000
cash, cash equivalents and restricted cash of continuing operations at end of period																									-6,234,000	46,476,000
net cash provided from operating activities																											127,594,000	140,727,000			195,635,000	199,930,000			130,948,000	196,126,000			104,136,000	172,116,000			178,807,000	159,413,000			138,619,000	157,931,000			105,957,000	134,702,000			90,098,000	100,079,000			85,079,000	105,392,000			72,918,000	106,731,000			68,278,000	83,131,000			89,410,000	62,826,000					47,825,000	60,716,000				47,060,000
proceeds from maturities of investments																											3,200,000	4,515,000	2,495,000	3,500,000	4,895,000	13,225,000	3,420,000	3,870,000	9,085,000	7,220,000	12,890,000	12,130,000										4,050,000				13,163,000				12,530,000								6,390,000	5,200,000	6,475,000
payments on capital lease obligations																											-343,000	-377,000	-321,000	-315,000	-645,000	-624,000	-421,000	-577,000	-529,000	-674,000	-391,000	-536,000	-1,108,000	-608,000	-296,000	-159,000	-75,000	-42,000	-17,000	-25,000	-23,000	-23,000	-23,000	-30,000	-15,000	-35,000	-43,000	-43,000	-50,000	-59,000	-259,000	-95,000						-70,000	-90,000	-85,000		-64,000	-52,000	-310,000		-47,000							-70,000	-65,000			-113,000	-91,000			-38,000	-51,000
excess tax benefit from exercises of stock options and vesting of restricted stock																																						319,000				1,076,000								2,414,000	2,059,000	729,000	1,716,000	1,990,000	145,000	1,743,000	4,841,000	302,000	790,000	115,000	1,728,000	410,000					95,000	85,000	1,653,000	2,298,000	248,000	6,505,000	1,275,000	612,000
net cash (used in) provided from financing activities																											-30,321,000	-135,516,000																			-79,016,000																						-37,893,000	-92,430,000	-29,958,000
cash, cash equivalents and restricted cash at end of year
equipment financed through capital leases
cash, cash equivalents and restricted cash at end of period																												-3,595,000	-2,883,000	60,939,000
other long term assets
excess tax benefit from exercises of stock options and vesting of restricted and deferred stock
other assets																																1,775,000	-1,068,000	-2,357,000				1,164,000	-5,341,000	3,121,000	3,154,000	705,000	457,000	1,048,000	291,000	341,000	-533,000	-3,187,000	266,000	-87,000	399,000	214,000	561,000	-21,000	-89,000	1,300,000	222,000	2,499,000	-2,514,000	-185,000	-414,000	-488,000	-2,108,000	-327,000	539,000	227,000	992,000	-4,000	224,000	146,000	-100,000	383,000	-584,000	274,000			-18,000	-853,000	100,000	-69,000		74,000	-64,000	81,000
excess tax benefit from vesting of restricted stock and exercises of stock options
net change in fair value of contingent consideration liabilities																																			180,000	98,000	220,000	274,000	29,000	245,000	-550,000	289,000	89,000	-966,000	114,000	346,000
equity in earnings of unconsolidated affiliate																																			-806,000	-796,000	-789,000	-794,000	-777,000	-784,000	-745,000	-821,000	-905,000	-725,000
distribution of earnings from unconsolidated affiliate																																			0				0	0	0	2,062,000
value of common stock issued for an acquisition
excess tax benefit from vesting of restricted stock and exercises from stock options																																				70,000
prepaid expenses and other assets																																					-3,498,000	1,273,000	-425,000	-1,800,000	-4,679,000	1,999,000	4,674,000	-113,000	-1,575,000	-1,480,000	1,123,000	1,340,000	-3,614,000	1,363,000	-2,033,000	2,529,000	-2,895,000	2,155,000	1,593,000	-5,067,000	291,000	-250,000	250,000	279,000	-175,000	3,528,000	41,000	4,032,000	-6,332,000	1,071,000	-2,232,000	1,039,000	-2,345,000	486,000	-4,551,000	-538,000	-1,855,000	1,852,000			76,000	885,000				-745,000
borrowings on credit facility																																							275,000,000	432,000,000	780,000,000	634,500,000
payments on credit facility																																							-1,099,500,000	-366,000,000	-384,000,000	-306,500,000
net cash provided from (used in) financing activities																																											-61,677,000								100,302,000														-27,385,000	42,414,000																		15,372,000
proceeds from sales or maturities of investments																																								9,180,000	10,763,000	3,265,000	6,235,000	6,450,000	4,415,000	3,635,000				2,015,000				7,200,000				4,850,000	3,975,000	7,500,000	1,000,000	3,100,000					7,949,000	6,500,000	3,714,000	6,570,000	46,345,000	72,960,000	63,015,000	56,254,000
excess tax benefit from vesting of restricted and deferred stock and exercises of stock options
payments for credit facility financing costs
non-cash financing activities:
excess tax benefit from exercises of stock options																																												1,343,000	7,881,000	1,935,000																				57,000
payments for amendment of line of credit
accretion of contingent consideration liabilities																																																610,000	464,000	242,000	232,000	246,000	252,000	265,000	266,000	273,000	279,000	265,000	250,000	268,000	274,000	175,000
excess tax benefit from exercises of stock options and vesting of restricted stock and deferred stock																																																2,562,000
excess tax benefit related to resolution of income tax matters																																																											0
gain on sale of discontinued operating unit
proceeds from sale of discontinued operating unit
payments for syndication of line of credit																																																																																	0
payments on long-term debt and capital lease obligations																																																											-61,000	-53,000	-81,000	-67,000												-285,000			-74,000				-66,000
cash held by discontinued operating unit
payment of contingent consideration liability																																																												0
gain on sale of assets																																																																				0	1,906,000	-38,143,000												0
purchase of investments																																																																-5,707,000	-10,014,000	-3,880,000	-5,615,000	-11,922,000	-3,997,000	-4,693,000	-32,761,000	-89,644,000					-3,665,000
purchase of property and equipment																																																																-2,803,000	-3,574,000	-4,484,000	-2,729,000	-4,764,000	-3,275,000	-4,912,000	-3,642,000	-1,522,000					-2,313,000	-1,411,000	-2,630,000	-1,531,000	-1,830,000	-1,421,000	-1,407,000	-2,399,000	-1,531,000	-11,403,000	-1,024,000	-1,316,000
proceeds from sale of assets																																																																				0	0	66,000,000											0	0
payments on syndication of line of credit
excess tax benefit related to stock option exercises and restricted stock vestings																																																																609,000
cash held by discontinued operating unit at beginning of period																																																																				0	0	50,000
cash held by discontinued operating unit on sale date																																																																				0	0	-72,000
net cash (used in) provided from investing activities																																																																	-59,108,000	-13,392,000
reduction of excess tax benefit related to stock option exercises and restricted stock vestings
acquisition payments
net cash provided from investing activities																																																																					-44,657,000	56,410,000
recognition of tax benefits from uncertain tax positions
cash held by discontinued operating unit at end of year
recognition of tax benefit from uncertain tax position																																																																								0	0	-1,181,000
net cash provided from (used in) investing activities																																																																									-5,368,000	29,289,000
net income, as restated
add: stock based compensation expense related to stock options and restricted stock included in restated net income, net of related tax effects
deduct: total stock-based employee compensation expense related to stock options and restricted stock determined under fair value accounting rules net of related tax effect
pro forma net income, as restated
net income per share
as restated:
basic
diluted
pro forma, as restated:
•
purchase of short-term investments																																																																															-4,575,000	-3,871,000
maturities of short-term investments																																																																															4,500,000	2,500,000
payments to refinance line of credit																																																																														0	0	-172,000
equity-based compensation expense																																																																													5,476,000
maturities of investments																																																																													3,600,000
(payments) borrowings on line of credit
non-cash financing activity:
common stock issued for convertible notes
purchase of treasury stock																																																																																		-34,127,000			0	-25,233,000	-24,787,000	-49,982,000
adjustments to reconcile net income to net cash provided from (used in) operating activities:
net cash provided from (used in) operating activities																																																																																656,000
cash flows provided from (used in) investing activities:
cash flows provided from (used in) financing activities:
income taxes payable/receivable																																																																																		6,151,000
payments on long-term debt, capital lease obligations and note payable
adjustments to reconcile net income to net cash (used in) provided from operating activities:
physician group acquisition payments																																																																																								-2,660,000
cash flows used in investing activities:

We provide you with 20 years of cash flow statements for MEDNAX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MEDNAX stock. Explore the full financial landscape of MEDNAX stock with our expertly curated income statements.

The information provided in this report about MEDNAX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.